Market Cap
$472.65M
Shares Outstanding
57.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 31, 2013
Round Lot
100
Locale
US
Day Open
$8.41
Day High
$8.75
Day Low
$8.41
Volume
140.8K
VWAP
$8.63
Prev Close
$8.19
Transactions
--
Acc. Volume
--
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Kamada Ltd (KMDA) closed the 2026-09-17 session at $8.67, up 5.86% versus the previous close (+0.48). The stock opened at $8.41 and traded between $8.41 and $8.75 during that session. Session trading volume was 141K shares. The volume-weighted average price (VWAP) is $8.63.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Kamada Ltd has a market capitalization of $472.6 million. KMDA is listed on the XNAS exchange. The company employs approximately 462 people. The recorded listing date is 2013-05-31.
On this page you can find market KMDA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.